Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q1

2372.TEDINET S100OU1N
Period2022-04-01 → 2022-06-30
Filed2022-08-05
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥4.8bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥15.7bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥3.4bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥1.4bn2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥354m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥1.4bn2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥2.6bn2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥439m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥1.5bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥440m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥258m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥1.1bn2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥255m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥28.2bnat 2022-06-30Cons.Assets
Total assets¥26.6bnat 2022-03-31Cons.Assets
Total assets¥21.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥17.2bnat 2022-06-30Cons.Liabilities
Total liabilities¥16.4bnat 2022-03-31Cons.Liabilities
Net assets / equity¥11.0bnat 2022-06-30Cons.Net assets
Net assets / equity¥10.2bnat 2022-03-31Cons.Net assets
Net assets / equity¥8.6bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥5.9bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥6.4bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥88.372022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥162.52021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.482021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥88.222022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥162.172021-04-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥21.422021-04-01 → 2021-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio38.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio38.1%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.3%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 62
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥23m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥3m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥19m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥45m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥357m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥364m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2022-04-01 → 2022-06-30¥385m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2022-04-01 → 2022-06-30¥374m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥10m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2022-04-01 → 2022-06-30¥42m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-06-30¥1.3bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥75m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-06-30¥61m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-06-30¥468m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-06-30¥241m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥226m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-06-30¥36m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-06-30¥2.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥24m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
—segment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥337m
—segment totalsegment profit2022-04-01 → 2022-06-30¥1.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥5.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥4.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥357m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥1.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥4m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-04-01 → 2021-06-30¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥60m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-06-30−¥217m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-06-30−¥217m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-06-30−¥303m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue2021-04-01 → 2021-06-30¥166m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue external2021-04-01 → 2021-06-30¥164m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥1m
jpcrp040300-q1r_E05352-000Advanced Medicinal Treatmentreportable segmentsegment profit2021-04-01 → 2021-06-30−¥162m
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue2021-04-01 → 2021-06-30¥1.1bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.1bn
jpcrp040300-q1r_E05352-000CROreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥16m
jpcrp040300-q1r_E05352-000CROreportable segmentsegment profit2021-04-01 → 2021-06-30¥71m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue2021-04-01 → 2021-06-30¥390m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue external2021-04-01 → 2021-06-30¥228m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥161m
jpcrp040300-q1r_E05352-000Medical Supportreportable segmentsegment profit2021-04-01 → 2021-06-30¥21m
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue external2021-04-01 → 2021-06-30¥1.9bn
jpcrp040300-q1r_E05352-000SMOreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥35m
jpcrp040300-q1r_E05352-000SMOreportable segmentsegment profit2021-04-01 → 2021-06-30¥787m
—segment totalrevenue2021-04-01 → 2021-06-30¥3.6bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥3.4bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥215m
—segment totalsegment profit2021-04-01 → 2021-06-30¥717m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥3.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥3.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥217m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥657m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 404
ItemContextValueUnit
Number of shares held in own name treasury shares etcCurrentQuarterInstant230200
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant230200
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0187
Cash and depositsPrior1YearInstant6400000000JPY
Cash and depositsCurrentQuarterInstant5909000000JPY
Accounts receivable tradePrior1YearInstant2846000000JPY
Accounts receivable tradeCurrentQuarterInstant3750000000JPY
Merchandise and finished goodsPrior1YearInstant277000000JPY
Merchandise and finished goodsCurrentQuarterInstant276000000JPY
Real estate for salePrior1YearInstant1535000000JPY
Real estate for saleCurrentQuarterInstant1537000000JPY
Work in processPrior1YearInstant502000000JPY
Work in processCurrentQuarterInstant526000000JPY
Raw materials and suppliesPrior1YearInstant312000000JPY
Raw materials and suppliesCurrentQuarterInstant325000000JPY
Short term loans receivablePrior1YearInstant785000000JPY
Short term loans receivableCurrentQuarterInstant788000000JPY
Other caPrior1YearInstant718000000JPY
Other caCurrentQuarterInstant1018000000JPY
Allowance for doubtful accounts caPrior1YearInstant-242000000JPY
Allowance for doubtful accounts caCurrentQuarterInstant-245000000JPY
Current assetsPrior1YearInstant13136000000JPY
Current assetsCurrentQuarterInstant13885000000JPY
Buildings and structures netPrior1YearInstant6470000000JPY
Buildings and structures netCurrentQuarterInstant6570000000JPY
Tools furniture and fixtures netPrior1YearInstant466000000JPY
Tools furniture and fixtures netCurrentQuarterInstant442000000JPY
Machinery equipment and vehicles netPrior1YearInstant331000000JPY
Machinery equipment and vehicles netCurrentQuarterInstant55000000JPY
LandPrior1YearInstant209000000JPY
LandCurrentQuarterInstant210000000JPY
Construction in progressPrior1YearInstant496000000JPY
Construction in progressCurrentQuarterInstant1488000000JPY
Property plant and equipmentPrior1YearInstant7975000000JPY
Property plant and equipmentCurrentQuarterInstant8766000000JPY
GoodwillPrior1YearInstant1053000000JPY
GoodwillCurrentQuarterInstant1035000000JPY
Other iaPrior1YearInstant75000000JPY
Other iaCurrentQuarterInstant70000000JPY
Intangible assetsPrior1YearInstant1128000000JPY
Intangible assetsCurrentQuarterInstant1105000000JPY
Investment securitiesPrior1YearInstant2446000000JPY
Investment securitiesCurrentQuarterInstant2522000000JPY
Long term loans receivablePrior1YearInstant547000000JPY
Long term loans receivableCurrentQuarterInstant587000000JPY
Guarantee deposits ioaPrior1YearInstant1008000000JPY
Guarantee deposits ioaCurrentQuarterInstant1009000000JPY
Deferred tax assetsPrior1YearInstant174000000JPY
Deferred tax assetsCurrentQuarterInstant122000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass